Hakseung Kim

Hakseung Kim

Auto-generated profile, based on publicly available information

Hakseung Kim

Department of Brain and Cognitive Engineering, Korea University, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
HKHakseung Kim
Hakseung Kim
HJHee Ra Jung
Hee Ra Jung
JKJung Bin Kim
Jung Bin Kim
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim
Kim H, et al. J Clin Neurol. 2022 Mar;18(2):140-151. https://doi.org/10.3988/jcn.2022.18.2.140

5 May 2022 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DKDong-Kyu Kim
Dong-Kyu Kim
YKYoung-Tak Kim
Young-Tak Kim
HKHakseung Kim
Hakseung Kim
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim
Arterial blood pressure (ABP) monitoring may permit the early diagnosis and management of cardiovascular disease (CVD); however, existing methods for measuring ABP outside the clinic use inconvenient cuff sphygmomanometry, or do not estimate continuous ABP waveforms. This study proposes a novel deep learning model DeepCNAP for estimating continuous BP waveform from a noninvasively measured photoplethysmography (PPG) signal in real-time. DeepCNAP was designed through the combination of deep convolutional networks and self-attention. The proposed method was constructed via 10-fold cross-validation based on the MIMIC database (the number of subjects = 942, recording time = 374.43 hours). The performance of DeepCNAP was evaluated from two perspectives: estimating ABP from PPG and classifying hemodynamically unstable events (i.e., hypertension, prehypertension, hypotension, and the normal state). The mean absolute errors of the BP estimates were 3.40 ± 4.36 mmHg for systolic BP, 1.75 ± 2.25 mmHg for diastolic BP, and 3.23 ± 2.21 mmHg for the BP waveform, indicating that DeepCNAP satisfies the standards of both the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI). From the estimated BP, hypertension, prehypertension, hypotension, and the normal state were classified with 99.44, 97.58, 92.23, and 94.64% accuracy, respectively. DeepCNAP enables feasible real-time estimation of invasively measured ABP from noninvasive PPG. With its noninvasive nature, high accuracy, and clinical relevance, the proposed model could be valuable in general wards at hospitals and for wearable devices in daily life.

1 June 2021 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
HLHack-Jin Lee
Hack-Jin Lee
HKHakseung Kim
Hakseung Kim
YKYoung-Tak Kim
Young-Tak Kim
KWKanghee Won
Kanghee Won
MCMarek Czosnyka
Marek Czosnyka
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim
Intracranial hypertension (IH) following acute phase traumatic brain injury (TBI) is associated with high mortality. Objective: This study proposes a novel parameter that may identify a potentially life-threatening IH (LTH) event and designs a machine learning model to predict LTH. Continuous recordings of intracranial pressure (ICP) and arterial blood pressure (ABP) from 273 TBI patients were used as the development dataset. The pressure-time dose (PTD) and pressure reactivity index (PRx) were calculated for each IH event, and an IH event with PRx > 0 and PTD > 5 was considered an LTH event. The association between the LTH parameters accumulated over five days and mortality was analyzed. A categorical boosting (CatBoost) model was employed to predict the occurrence of a future LTH event from the onset of IH using the ABP- and ICP-related parameters. Training and validation were performed on a total of 5,938 IH events. External performance evaluation was performed in 307 IH events included in the Cerebral Haemodynamic Autoregulatory Information System (CHARIS) database. The performance of the proposed model was evaluated through the area under the receiver operating characteristic curve (AUROC). The LTH parameters were able to distinguish between the deceased and surviving patients (AUROC > 0.7, p < 0.001). The CatBoost model predicted LTH with an AUROC = 0.7 on the external test dataset. This study demonstrated that the proposed LTH prediction model has a reasonable predictive capacity for mortality. The CatBoost model anticipates whether an IH event will develop into an LTH event. The findings of this study support the usefulness of ICP monitoring.

1 September 2024 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
KKKyung Ah Kim
Kyung Ah Kim
HKHakseung Kim
Hakseung Kim
EHEunjin Ha
Eunjin Ha
BYByung C. Yoon
Byung C. Yoon
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim
In neurointensive care units (NICUs), particularly in cases involving traumatic brain injury (TBI), swift and accurate decision-making is critical because of rapidly changing patient conditions and the risk of secondary brain injury. The use of artificial intelligence (AI) in NICU can enhance clinical decision support and provide valuable assistance in these complex scenarios. This article aims to provide a comprehensive review of the current status and future prospects of AI utilization in the NICU, along with the challenges that must be overcome to realize this. Presently, the primary application of AI in NICU is outcome prediction through the analysis of preadmission and high-resolution data during admission. Recent applications include augmented neuromonitoring via signal quality control and real-time event prediction. In addition, AI can integrate data gathered from various measures and support minimally invasive neuromonitoring to increase patient safety. However, despite the recent surge in AI adoption within the NICU, the majority of AI applications have been limited to simple classification tasks, thus leaving the true potential of AI largely untapped. Emerging AI technologies, such as generalist medical AI and digital twins, harbor immense potential for enhancing advanced neurocritical care through broader AI applications. If challenges such as acquiring high-quality data and ethical issues are overcome, these new AI technologies can be clinically utilized in the actual NICU environment. Emphasizing the need for continuous research and development to maximize the potential of AI in the NICU, we anticipate that this will further enhance the efficiency and accuracy of TBI treatment within the NICU.

13 September 2024 in Expert Systems with Applications
Verified
Journal Article
Open access
CLChoel-Hui Lee
Choel-Hui Lee
DADaesun Ahn
Daesun Ahn
HKHakseung Kim
Hakseung Kim
EHEunjin Ha
Eunjin Ha
JKJung Bin Kim
Jung Bin Kim
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim

9 September 2025 in IEEE Transactions on Cybernetics
Verified
Journal Article
Open access
CLCheol-Hui Lee
Cheol-Hui Lee
HKHakseung Kim
Hakseung Kim
BYByung Chul Yoon
Byung Chul Yoon
Dong-Joo KimDong-Joo Kim
Dong-Joo Kim
Sleep is essential for maintaining human health and quality of life. Analyzing physiological signals during sleep is critical in assessing sleep quality and diagnosing sleep disorders. However, manual diagnoses by clinicians are time-intensive and subjective. Despite advances in deep learning that have enhanced automation, these approaches remain heavily dependent on large-scale labeled datasets. This study introduces SynthSleepNet, a multimodal hybrid-self-supervised learning (SSL) framework designed for analyzing polysomnography (PSG) data. SynthSleepNet effectively integrates masked prediction and contrastive learning to leverage complementary features across multiple modalities, including electroencephalogram (EEG), electrooculography (EOG), electromyography (EMG), and electrocardiogram (ECG). This approach enables the model to learn highly expressive representations of PSG data. Furthermore, a TCM based on Mamba was developed to efficiently capture contextual information across signals. SynthSleepNet achieved superior performance compared to state-of-the-art methods across three downstream tasks: sleep-stage classification, apnea detection, and hypopnea detection, with accuracies of 89.89%, 99.75%, and 89.60%, respectively. The model demonstrated robust performance in a semi-SSL environment with limited labels, achieving accuracies of 87.98%, 99.37%, and 77.52% in the same tasks. These results underscore the potential of the model as a foundational tool for the comprehensive analysis of PSG data. SynthSleepNet demonstrates comprehensively superior performance across multiple downstream tasks compared to other methodologies, making it expected to set a new standard for sleep disorder monitoring and diagnostic systems. The source code is available at https://github.com/dlcjfgmlnasa/SynthSleepNet.